Richard Shan

机构：Fulcrum Therapeutics (United States), Quintara Biosciences (United States), Stella Therapeutics (United States)

发表论文 8 篇 · 总被引 55 次 · h-index 3

代表论文

Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration (2024 · Nature Biotechnology · 被引 34)
Immune evasive DNA donors and recombinases license kilobase-scale writing (2026 · Nature · 被引 9)
Engineering tripartite gene editing machinery for highly efficient non-viral targeted genome integration (2025 · Nature Communications · 被引 6)
Circular single-stranded DNA is a superior homology-directed repair donor template for efficient genome engineering (2022 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 3)
Engineering Tripartite Gene Editing Machinery for Highly Efficient Non-Viral Targeted Genome Integration (2023 · Research Square · 被引 2)
TESOGENASE, An Engineered Nuclease Editor for Enhanced Targeted Genome Integration (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)